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A nosocomial polyclonal outbreak associated to bacteremia caused by different Burkholderia
cepacia complex (BCC) species and clones is reported. Molecular characterization identiﬁed
Burkholderia stabilis,  Burkholderia contaminans, and Burkholderia ambifaria among BCC isolates
obtained from patients in neonatal and adult intensive care units. BCC was also isolated
from an intrinsically contaminated ultrasound gel, which constituted the presumptive BCC
source. Prior BCC outbreak related to contaminated ultrasound gels have been described in
the  setting of transrectal prostate biopsy. Outbreak caused strains and/or clones of BCC have
been reported, probably because BCC are commonly found in the natural environment; most
BCC species are bioﬁlm producers, and different species may contaminate an environmentalolyclonal source. The ﬁnding of multiple species or clones during the analysis of nosocomial BCC cases
might not be enough to reject an outbreak from a common source.
©  2015 Elsevier Editora Ltda. All rights reserved.
by BCC strains between April and July 2013. Subject’s clinicalhe Burkholderia cepacia complex (BCC) encompasses at least
7 related Gram-Negative bacilli species as judged by differ-
nt phenotypic and genotypic analyses.1 BCC members can
ause infections in cystic ﬁbrosis, chronic granulomatous dis-
ase, and hospitalized patients.2 BCC members are among
he most frequent sources of nosocomial outbreaks due to
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E-mail  address: esteban.nannini@sanbritanico.com.ar (E.C. Nannini
ttp://dx.doi.org/10.1016/j.bjid.2015.06.009
413-8670/© 2015 Elsevier Editora Ltda. All rights reserved.intrinsically contaminated substances other than blood
products.2 Here, we describe an outbreak of bacteremia causeditánico, Paraguay 40, Rosario (2000), Santa Fe, Argentina.
).
charts were reviewed and microbiological testing of sub-
stances and solutions representing potential sources of the
outbreak was performed. Eighty samples from different wards
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Table 1 – Description of the 12 Burkholderia cepacia complex strains isolated from blood cultures and from ultrasound
lubricant gel.
Date of positive culture Origin Patient (P) or gel sample
(G) number
BCC  species by recA
sequencing
Clone by
DO-PCR
04/05/2013 NU P1 B. ambifaria A
04/09/2013 NU P2 B. ambifaria A
04/13/2013 ICU P3 B. stabilis B
04/14/2013 ICU P3 B. stabilis B
04/27/2013 ICU P4 B. ambifaria C
04/30/2013 ICU P4 B. ambifaria C
05/04/2013 ICU P5 B. stabilis B
05/04/2013 ICU P4 B. ambifaria C
05/08/2013 NU P6 B. contaminans D
06/05/2013 UO G1 B. contaminans E
06/05/2013 OW G2 B. contaminans E
06/12/2013 Gel container G3 B. contaminans E
NU, Neonatal Unit; ICU, Intensive Care Unit; UO, Ultrasound Ofﬁce; OW,  Obstetric Ward, DO-PCR, degenerate oligonucleotide-PCR.and commercial products commonly used in the Neonatal
Unit (NU) and Intensive Care Unit (ICU) were tested for BCC
presence using selective culture media (Burkholderia agar,
BioMerieux Inc, Mercy  Le´toil, France). All suspected isolates
were phenotypically identiﬁed as belonging to the BCC by oxi-
dase, OF-glucose, sculin hydrolysis, lysine decarboxylation,
and DNA hydrolysis tests, as well as by the semi-automatized
API-20NE (BioMerieux Inc, Mercy  Le´toil, France) method.
Regrettably, only nine BCC isolates were available for molecu-
lar analysis (six from blood cultures and three from ultrasound
gels). These strains were identiﬁed to the species level by
recA gene sequence comparisons3 and analyzed for genomic
relatedness by both degenerate oligonucleotide-primed PCR4
and repetitive extragenic palindromic-PCR.5
The outbreak involved 11 patients with 17 BCC isolates
recovered from blood cultures; seven of these 11 subjects were
hospitalized in the NU, all of them were preterm neonates
with respiratory distress, three other patients were in the
ICU, two of which had recent cardiovascular surgery, and one
patient was in the General Ward. The mean (range) time of
hospitalization of these patients until the development the
bacteremia was 5.55 (0–15) days; one neonate developed BCC
bacteremia the date of birth, probably reﬂecting horizontal
transmission. In seven patients, BCC strains were recov-
ered only from baseline blood cultures; two more  patients
had positive surveillance blood cultures on day 2, and two
other patients had bacteremia also in a 3rd set of blood cul-
tures. Three of the 11 patients died (two adults and one
neonate) during the hospitalization, although none of these
deaths were attributed to the BCC bacteremic episode. It was
noted that the seven neonates and the four adult patients
underwent a mean (range) of 5 (1–10) ultrasounds, including
transthoracic and transfontanellar ones, and 2 (1–3), respec-
tively.
Eighty environmental samples were taken for culture,
including several solutions of antiseptics (iodopovidone,
hydrogen peroxide, cholorhexidine, and alcohol-gel), drugs
(fentanyl citrate, morphine, tobramycin drops), multiple sur-
faces in the surgical room, ICU and NU, and other commonlyused materials such as gels for ultrasound, liquid soap, and
vaseline; BCC strains were isolated only from ultrasound
scanning gels (Table 1). A quantitative culture done from an
unopened 5-L container ultrasound gel displayed growth of
4.66 log10 CFU/mL (mean of two samples) of BCC cells. Molec-
ular analyses based on recA gene sequence of nine isolates
obtained from six patients in NU and ICU wards indicated
the presence of three different species of the BCC complex
(Table 1): Burkholderia ambifaria was identiﬁed in patients 1 and
2 (NU) and patient 4 (ICU), Burkholderia stabilis in patient 3 and
5 (ICU), and Burkholderia contaminans in patient 6 (NU). All BCC
isolates were susceptible to ceftazidime, meropenem, minocy-
cline, and trimethoprim-sulfamethoxazole by disk diffusion
methods.
Among the clinical isolates, genotypic characterization
revealed two different clones of B. ambifaria and a single
clone of both, B. stabilis and B. contaminans (Table 1). Two
different BCC species coexisted in the NU (B. ambifaria and
B. contaminans) and the ICU (B. stabilis and B. ambifaria).  In
addition, two different B. ambifaria clones were detected,
both from different wards (Table 1). B. contaminans was iso-
lated in different samples of ultrasound gel as it was from
patient 6 although this isolate was a different clone (Table 1).
Repetitive extragenic palindromic-PCR conﬁrmed the clonal
distinctness of the BCC isolates analyzed above (data not
shown). These results support the polyclonal outbreak of BCC
strains caused by multiple species (B. ambifaria,  B. stabilis,
and B. contaminans) and clones (e.g. B. ambifaria, B. contami-
nans).
Interesting, BCC members can hydrolyze parabens, which
are p-hydroxybenzoic acid esters with antimicrobial proper-
ties commonly added as stabilizers to ultrasound gels6; BCC
strains can therefore survive and proliferate in these gels.6
Even though the sterility of substances in contact with intact
skin such as ultrasound gels is generally not required, the US
Food and Drug Administration had to recall commercial ultra-
sound gels contaminated with Pseudomonas aeruginosa and
Klebsiella oxytoca, recommending the use of sterile ultrasound
gel for invasive procedures, leaving the use of non-sterile
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open) containers for procedures performed on intact skin and
or low risk patients.7 Of note, BCC invasive infections related
o contaminated ultrasound gels have been only described
n the setting of transrectal prostate biopsy.6,8 Current report
epresents the third outbreak of BCC presumably associated
o ultrasound gel. We  speculate that the invasive procedures
one in neonate hosts and patients undergoing cardiovascular
urgery might have predisposed them to develop bacteremia
fter signiﬁcant BCC skin colonization from contaminated gel.
The striking feature of this outbreak is the presence
f multiple BCC species and clones since most BCC out-
reaks have been associated to a single clone. However,
utbreaks caused by different strains and/or clones have been
eported,9–11 including BCC contamination of hospital water,9
ntravenous bromopride vials,10 and non-identiﬁed environ-
ental sources.11 Since BCC bacteria are commonly found in
he natural environment and most BCC species are bioﬁlm
roducers, different species may contaminate an environ-
ental source (as it has been described in cystic ﬁbrosis
atients12), eventually leading to a polyclonal nosocomial out-
reak. Unfortunately, we  could not conﬁrm this hypothesis as
e only recovered one B. contaminans clone from the ultra-
ound gel samples.
In summary, the sudden appearance of BCC invasive
ases, the isolation of BCC from ultrasound gels including an
nopened container, and the abrupt interruption of new cases
fter removal of ultrasound gel stocks led us to speculate that
his substance might have been the source of the nosocomial
CC outbreak. The ﬁnding of multiple species or clones during
he analysis of nosocomial BCC cases might not be enough to
eject an outbreak from a common source.
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